Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KURAKura Oncology, Inc.

Nasdaq · CIK 0001422143
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts316

Identity from submissions API

NameKura Oncology, Inc.
CIK0001422143
TickersKURA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN611547851
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 500-8800
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ZETA ACQUISITION CORP III (2008-02-01T05:00:00.000Z → 2015-03-10T04:00:00.000Z)
Business address
4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO
CA
92121
CA
Mailing address
4930 DIRECTORS PLACE, SUITE 500
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

828 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468898 4882
2026-11-19 144 xsl144X01/primary_doc.xml 0001950047-26-011354 001-37620 261575191 33 8423
2026-11-18 D xslFormDX01/primary_doc.xml 06b 0001231919-26-001602 021-605234 261571165 33 16890
2026-11-18 4 4 0001193125-26-467083 15907
2026-11-18 4 4 0001193125-26-467081 17177
2026-11-18 4 4 0001193125-26-467080 16759
2026-11-18 4 4 0001193125-26-467078 14959
2026-11-18 4 4 0001193125-26-467076 17161
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011249 001-37620 261566715 33 7719
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011229 001-37620 261566546 33 6981
2026-11-17 144 xsl144X01/primary_doc.xml 0001950047-26-011228 001-37620 261566542 33 6978
2026-11-17 4/A 4/A 0001193125-26-465499 9205
2026-11-16 4 4 0001193125-26-464166 18310
2026-11-16 144 xsl144X01/primary_doc.xml 0001193125-26-464154 001-37620 261563561 33 14495
2026-11-16 144 xsl144X01/primary_doc.xml 0001193125-26-464153 001-37620 261563559 33 14432
2026-11-16 144 xsl144X01/primary_doc.xml 0001193125-26-464152 001-37620 261563560 33 13787
2026-11-16 144 xsl144X01/primary_doc.xml 0001193125-26-464150 001-37620 261563558 33 15852
2026-11-16 144 xsl144X01/primary_doc.xml 0001193125-26-464151 001-37620 261563557 33 14493
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003183 005-83933 261561304 34 23773
2026-11-10 S-3ASR S-3ASR 0001193125-26-455759 333-299972 261541580 33 2351330 1 1
2026-11-10 10-Q 10-Q 0001193125-26-455455 001-37620 261540438 34 10686056 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-455416 001-37620 261540252 34 503650 1 1
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003813 005-83933 261491642 34 11114
2026-09-29 4 4 0001193125-26-407939 5405
2026-09-29 4 4 0001193125-26-407938 7592
2026-09-29 4 4 0001193125-26-407937 7593
2026-09-29 4 4 0001193125-26-407936 6318
2026-09-29 4 4 0001193125-26-407935 9154
2026-09-29 144 xsl144X01/primary_doc.xml 0001950047-26-009866 001-37620 261424178 33 6982
2026-09-29 144 xsl144X01/primary_doc.xml 0001950047-26-009865 001-37620 261424173 33 5562
2026-09-29 144 xsl144X01/primary_doc.xml 0001950047-26-009864 001-37620 261424168 33 5553
2026-09-28 144 xsl144X01/primary_doc.xml 0001193125-26-405751 001-37620 261418848 33 5715
2026-09-28 144 xsl144X01/primary_doc.xml 0001193125-26-405713 001-37620 261418761 33 4313
2026-09-28 144 xsl144X01/primary_doc.xml 0001193125-26-405712 001-37620 261418760 33 4997
2026-09-28 144 xsl144X01/primary_doc.xml 0001193125-26-405711 001-37620 261418758 33 4313
2026-09-28 144 xsl144X01/primary_doc.xml 0001193125-26-405710 001-37620 261418757 33 4322
2026-09-28 144 xsl144X01/primary_doc.xml 0001950047-26-009845 001-37620 261417500 33 5561
2026-09-25 4 4 0001193125-26-402815 8979
2026-09-24 144 xsl144X01/primary_doc.xml 0001950047-26-009786 001-37620 261404821 33 4814
2026-09-10 4 4 0001193125-26-387934 5516
2026-09-10 3 3 0001193125-26-387926 13389
2026-09-09 8-K 8-K 8.01 0001193125-26-385881 001-37620 261366654 34 142418 1 1
2026-09-08 8-K 8-K 5.02 0001193125-26-384363 001-37620 261363351 34 144518 1 1
2026-08-24 4 4 0001193125-26-363812 6569
2026-08-24 4 4 0001193125-26-363810 5349
2026-08-21 144 xsl144X01/primary_doc.xml 0001950047-26-008548 001-37620 261305261 33 5006
2026-08-21 4 4 0001193125-26-361184 5465
2026-08-19 144 xsl144X01/primary_doc.xml 0001950047-26-008396 001-37620 261295488 33 5013
2026-08-17 4 4 0001193125-26-354201 6569
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-005536 005-83933 261282274 34 16816
2026-08-12 10-Q 10-Q 0001193125-26-346884 001-37620 261267683 34 7930496 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001193125-26-346856 001-37620 261267564 34 528321 1 1
2026-07-29 8-K 8-K 5.02 0001193125-26-324202 001-37620 261218814 34 144050 1 1
2026-06-22 4 4 0001193125-26-277780 5526
2026-06-18 144 xsl144X01/primary_doc.xml 0001950047-26-006310 001-37620 261102992 33 5025
2026-06-04 4 4 0001193125-26-257903 5321
2026-06-04 4 4 0001193125-26-257902 5382
2026-06-04 4 4 0001193125-26-257901 5359
2026-06-04 4 4 0001193125-26-257900 5337
2026-06-04 4 4 0001193125-26-257898 5322
2026-06-04 4 4 0001193125-26-257897 5334
2026-06-04 4 4 0001193125-26-257896 5371
2026-06-04 S-8 S-8 0001193125-26-257777 333-296511 261066078 33 465083 1 1
2026-06-04 8-K 8-K 5.02,5.07,9.01 0001193125-26-257368 001-37620 261064888 34 926749 1 1
2026-05-26 DEFA14A DEFA14A 0001193125-26-239481 001-37620 261020541 34 45670
2026-05-22 4 4 0001193125-26-236838 4884
2026-05-21 144 xsl144X01/primary_doc.xml 0001950047-26-004907 001-37620 261009056 33 5559
2026-05-20 4 4 0001193125-26-232547 5059
2026-05-20 4 4 0001193125-26-232548 5523
2026-05-20 4 4 0001193125-26-232546 5499
2026-05-19 144 xsl144X01/primary_doc.xml 0001950047-26-004793 001-37620 26999677 33 4854
2026-05-19 144 xsl144X01/primary_doc.xml 0001950047-26-004789 001-37620 26999615 33 4845
2026-05-18 144 xsl144X01/primary_doc.xml 0001950047-26-004689 001-37620 26994061 33 4855
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002164 005-83933 26984228 34 10671
2026-05-12 10-Q 10-Q 0001193125-26-219481 001-37620 26968753 34 7159617 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-219422 001-37620 26968573 34 448245 1 1
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000682 005-83933 26921294 34 7493
2026-04-10 ARS ARS 0001193125-26-151391 001-37620 26855484 34 1788624
2026-04-10 DEFA14A DEFA14A 0001193125-26-151363 001-37620 26855384 34 6327396
2026-04-10 DEF 14A DEF 14A 0001193125-26-151335 001-37620 26855203 34 15528880 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001712 005-83933 26801939 34 7258
2026-03-25 4 4 0001193125-26-122938 8367
2026-03-20 4 4 0001193125-26-116834 7709
2026-03-05 10-K 10-K 0001193125-26-092567 001-37620 26724204 34 17551883 1 1
2026-03-05 8-K 8-K 2.02,9.01 0001193125-26-092465 001-37620 26724120 34 495765 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001243 005-83933 26645089 34 10475
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000062 005-83933 26609559 34 8114
2026-01-29 8-K 8-K 5.03,9.01 0001193125-26-029705 001-37620 26579440 34 356993 1 1
2026-01-27 4 4 0001193125-26-025305 6274
2026-01-27 4 4 0001193125-26-025304 4720
2026-01-27 4 4 0001193125-26-025303 9387
2026-01-27 4 4 0001193125-26-025302 11652
2026-01-27 4 4 0001193125-26-025306 4726
2026-01-27 4 4 0001193125-26-025301 7804
2026-01-27 144 xsl144X01/primary_doc.xml 0001193125-26-025296 001-37620 26568026 33 4766
2026-01-27 144 xsl144X01/primary_doc.xml 0001193125-26-025295 001-37620 26568024 33 5207
2026-01-27 144 xsl144X01/primary_doc.xml 0001193125-26-025294 001-37620 26568023 33 4312
2026-01-27 144 xsl144X01/primary_doc.xml 0001193125-26-025293 001-37620 26568019 33 5681
2026-01-27 144 xsl144X01/primary_doc.xml 0001193125-26-025292 001-37620 26568018 33 4318
2026-01-27 144 xsl144X01/primary_doc.xml 0001193125-26-025291 001-37620 26568017 33 6151
2026-01-12 8-K 8-K 2.02,9.01 0001193125-26-009649 001-37620 26524537 34 204769 1 1
2026-01-06 4 4 0001193125-26-004580 5302
2026-01-06 4 4 0001193125-26-004570 6916
2026-01-06 4 4 0001193125-26-004569 7807
2026-01-06 4 4 0001193125-26-004567 6921
2026-01-06 4 4 0001193125-26-004566 5302
2026-01-06 4 4 0001193125-26-004564 6919
2026-01-06 4 4 0001193125-26-004562 6891
2025-12-19 4 4 0001193125-25-326948 8920
2025-12-18 144 xsl144X01/primary_doc.xml 0001950047-25-010487 001-37620 251583112 33 4814
2025-12-10 4 4 0001193125-25-314154 6556
2025-12-09 144 xsl144X01/primary_doc.xml 0001950047-25-010004 001-37620 251559378 33 4851
2025-12-02 8-K 8-K 8.01 0001193125-25-304559 001-37620 251541638 34 139632 1 1
2025-11-14 4 4 0001193125-25-283568 6633
2025-11-14 4 4 0001193125-25-283565 6680
2025-11-14 4 4 0001193125-25-283564 6252
2025-11-14 4 4 0001193125-25-283563 6676
2025-11-14 4 4 0001193125-25-283562 7365
2025-11-14 144 xsl144X01/primary_doc.xml 0001193125-25-283567 001-37620 251488974 33 4313
2025-11-14 144 xsl144X01/primary_doc.xml 0001193125-25-283566 001-37620 251488973 33 4322
2025-11-14 4 4 0001193125-25-283560 6659
2025-11-14 144 xsl144X01/primary_doc.xml 0001193125-25-283561 001-37620 251488972 33 4309
2025-11-14 144 xsl144X01/primary_doc.xml 0001193125-25-283559 001-37620 251488971 33 4291
2025-11-14 144 xsl144X01/primary_doc.xml 0001193125-25-283558 001-37620 251488970 33 4312
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005180 005-83933 251488782 34 10736
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003106 005-83933 251486268 34 25054
2025-11-13 8-K 8-K 8.01 0001193125-25-280255 001-37620 251478979 34 145848 1 1
2025-11-04 S-8 S-8 0001193125-25-263599 333-291242 251446471 33 179308 1 1
2025-11-04 10-Q 10-Q 0001193125-25-263589 001-37620 251446458 34 8087701 1 1
2025-11-04 8-K 8-K 2.02,9.01 0001193125-25-263491 001-37620 251446307 34 427736 1 1
2025-10-24 8-K 8-K 8.01 0001193125-25-249348 001-37620 251414284 34 136084 1 1
2025-10-16 8-K 8-K 8.01,9.01 0001193125-25-241416 001-37620 251397733 34 372332 1 1
2025-09-29 144 xsl144X01/primary_doc.xml 0001193125-25-223697 001-37620 251357832 33 4304
2025-09-29 144 xsl144X01/primary_doc.xml 0001193125-25-223696 001-37620 251357831 33 4319
2025-09-29 144 xsl144X01/primary_doc.xml 0001193125-25-223695 001-37620 251357830 33 4379
2025-09-29 144 xsl144X01/primary_doc.xml 0001193125-25-223694 001-37620 251357829 33 4306
2025-09-29 144 xsl144X01/primary_doc.xml 0001193125-25-223693 001-37620 251357828 33 4289
2025-09-29 144 xsl144X01/primary_doc.xml 0001193125-25-223692 001-37620 251357827 33 4310
2025-09-29 4 4 0001193125-25-223667 6085
2025-09-29 4 4 0001193125-25-223666 6672
2025-09-29 4 4 0001193125-25-223665 6666
2025-09-29 4 4 0001193125-25-223664 6681
2025-09-29 4 4 0001193125-25-223663 8105
2025-09-29 4 4 0001193125-25-223662 7524
2025-09-09 4 xslF345X05/form4-09092025_080937.xml 0001415889-25-023974 6619
2025-08-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003630 005-83933 251223538 34 10735
2025-08-14 4 4 0000950170-25-108844 8451
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000522 005-83933 251216990 34 16157
2025-08-07 10-Q 10-Q 0000950170-25-105051 001-37620 251194281 34 8656760 1 1
2025-08-07 8-K 8-K 2.02,9.01 0000950170-25-105024 001-37620 251194082 34 418379 1 1
2025-07-01 8-K 8-K 1.01 0001193125-25-153393 001-37620 251094090 34 141195 1 1
2025-06-18 8-K 8-K 8.01,9.01 0001193125-25-142816 001-37620 251057891 34 4737268 1 1
2025-06-06 S-8 S-8 0000950170-25-083276 333-287866 251032169 33 310151
2025-06-06 4 4 0000950170-25-083041 5206
2025-06-06 8-K 8-K 5.02,5.07,9.01 0000950170-25-083046 001-37620 251030539 34 711727 1 1
2025-06-06 4 4 0000950170-25-083040 5190
2025-06-06 4 4 0000950170-25-083037 5251
2025-06-06 4 4 0000950170-25-083038 5191
2025-06-06 4 4 0000950170-25-083039 5185
2025-06-06 4 4 0000950170-25-083036 5240
2025-06-06 4 4 0000950170-25-083035 5203
2025-06-03 8-K 8-K 8.01,9.01 0001193125-25-133717 001-37620 251017075 34 4438824 1 1
2025-05-19 4 4 0000950170-25-074660 4903
2025-05-19 4 4 0000950170-25-074659 5390
2025-05-19 144 xsl144X01/primary_doc.xml 0001969223-25-000329 001-37620 25963937 33 4455
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013210 005-83933 25955060 34 19004
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002262 005-83933 25951967 34 10728
2025-05-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-002736 005-83933 25909965 34 19164
2025-05-01 10-Q 10-Q 0000950170-25-061848 001-37620 25903298 34 6854211 1 1
2025-05-01 8-K 8-K 2.02,9.01 0000950170-25-061836 001-37620 25903171 34 332286 1 1
2025-04-17 ARS ARS 0000950170-25-055537 001-37620 25848129 34 24583371
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000619 005-83933 25844590 34 11078
2025-04-11 DEFA14A DEFA14A 0000950170-25-053354 001-37620 25832845 34 6197798
2025-04-11 DEF 14A DEF 14A 0000950170-25-053335 001-37620 25832803 34 18688227 1 1
2025-03-24 4 4 0000950170-25-043903 6506
2025-03-21 144 xsl144X01/primary_doc.xml 0001950047-25-002100 001-37620 25760789 33 5049
2025-02-28 S-8 S-8 0000950170-25-030015 333-285424 25690412 33 430969 1 1
2025-02-28 10-K 10-K 0000950170-25-029975 001-37620 25689859 34 22182957 1 1
2025-02-26 8-K 8-K 2.02 0000950170-25-027706 001-37620 25669927 34 372578 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001287 005-83933 25631252 34 10632
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014236 005-83933 25630098 34 11885
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-25-001296 005-83933 25622508 34 18826
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-000176 005-83933 25617425 34 15672
2025-02-05 8-K 8-K 8.01,9.01 0001193125-25-020831 001-37620 25593423 34 2890694 1 1
2025-02-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000249 005-83933 25590374 34 39759
2025-02-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000248 005-83933 25590371 34 24640
2025-01-28 4 4 0000950170-25-010137 10106
2025-01-28 4 4 0000950170-25-010121 9393
2025-01-28 4 4 0000950170-25-010120 6262
2025-01-28 4 4 0000950170-25-010118 4734
2025-01-28 4 4 0000950170-25-010117 6293
2025-01-28 4 4 0000950170-25-010116 4728
2025-01-28 144 xsl144X01/primary_doc.xml 0000950170-25-010114 001-37620 25566338 33 5681
2025-01-28 144 xsl144X01/primary_doc.xml 0000950170-25-010113 001-37620 25566336 33 4752
2025-01-28 144 xsl144X01/primary_doc.xml 0000950170-25-010111 001-37620 25566334 33 4316
2025-01-28 144 xsl144X01/primary_doc.xml 0000950170-25-010110 001-37620 25566333 33 5697
2025-01-28 144 xsl144X01/primary_doc.xml 0000950170-25-010109 001-37620 25566331 33 4775
2025-01-28 144 xsl144X01/primary_doc.xml 0000950170-25-010108 001-37620 25566330 33 4309
2025-01-14 8-K 8-K 1.01,2.03 0001193125-25-006197 001-37620 25529781 34 147000 1 1
2025-01-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-000069 005-83933 25519735 34 44877
2025-01-07 4 xslF345X05/form4-01072025_100104.xml 0001415889-25-001052 7163
2025-01-07 3 xslF345X02/form3-01072025_100147.xml 0001415889-25-001050 18922
2025-01-07 4 xslF345X05/form4-01072025_100138.xml 0001415889-25-001045 5495
2025-01-07 3 xslF345X02/form3-01072025_100150.xml 0001415889-25-001032 24024
2025-01-06 8-K 8-K 5.02,8.01 0001193125-25-002189 001-37620 25511710 34 146156 1 1
2025-01-06 4 4 0000950170-25-002072 9352
2025-01-06 4 4 0000950170-25-002062 6901
2025-01-06 4 4 0000950170-25-002056 6925
2025-01-06 4 4 0000950170-25-002049 5308
2025-01-06 4 4 0000950170-25-002046 5312
2024-12-20 8-K 8-K 8.01,9.01 0001193125-24-283109 001-37620 241567972 34 334978 1 1
2024-12-05 SC 13G SC 13G 0001104659-24-125975 005-83933 241530208 34 85640
2024-11-20 8-K 8-K 1.01 0001193125-24-262641 001-37620 241481385 34 160729 1 1
2024-11-19 4 4 0000950170-24-128558 5367
2024-11-18 144 xsl144X01/primary_doc.xml 0001973141-24-000561 001-37620 241471425 33 4461
2024-11-14 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0000921895-24-002726 005-83933 241463246 34 280634
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119017 005-83933 241463201 34 70644
2024-11-07 10-Q 10-Q 0000950170-24-123363 001-37620 241435952 34 5527398 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123321 001-37620 241435717 34 317284 1 1
2024-09-17 3 3 0000950170-24-107273 14365
2024-09-17 4 4 0000950170-24-107272 7485
2024-09-17 8-K 8-K 5.02 0001193125-24-220529 001-37620 241304265 34 146674 1 1
2024-08-08 10-Q 10-Q 0000950170-24-093997 001-37620 241188553 34 5594500 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093945 001-37620 241188359 34 314379 1 1
2024-06-07 S-8 S-8 0000950170-24-070722 333-280050 241030057 33 209943
2024-06-07 4 4 0000950170-24-070702 5211
2024-06-07 4 4 0000950170-24-070700 5198
2024-06-07 4 4 0000950170-24-070699 5199
2024-06-07 4 4 0000950170-24-070698 5248
2024-06-07 4 4 0000950170-24-070707 5193
2024-06-07 4 4 0000950170-24-070697 5214
2024-06-07 8-K 8-K 5.02,5.07,9.01 0000950170-24-070584 001-37620 241029269 34 658290 1 1
2024-05-24 8-K 8-K 8.01 0001193125-24-147030 001-37620 24984276 34 146821 1 1
2024-05-20 4 4 0000950170-24-062585 5608
2024-05-20 144 xsl144X01/primary_doc.xml 0001950047-24-003907 001-37620 24964779 33 4931
2024-05-02 SC 13G SC 13G 0001104659-24-056418 005-83933 24909068 34 65933
2024-05-02 10-Q 10-Q 0000950170-24-052136 001-37620 24908476 34 5016838 1 1
2024-05-02 8-K 8-K 2.02,9.01 0000950170-24-052109 001-37620 24908302 34 286852 1 1
2024-04-18 ARS ARS 0000950170-24-045542 001-37620 24854324 34 14249700
2024-04-12 DEFA14A DEFA14A 0000950170-24-044067 001-37620 24841823 34 1930804
2024-04-12 DEF 14A DEF 14A 0000950170-24-044066 001-37620 24841822 34 7281350 1 1
2024-02-29 UPLOAD filename1.pdf 0000000000-24-001681 333-276995 40434
2024-02-27 S-8 S-8 0001193125-24-048048 333-277411 24687928 33 107310
2024-02-27 10-K 10-K 0000950170-24-021094 001-37620 24686495 34 11362720 1 1
2024-02-27 8-K 8-K 2.02,9.01 0000950170-24-021087 001-37620 24686381 34 322589 1 1
2024-02-15 424B3 424B3 0001193125-24-037523 333-276995 24643692 33 167793
2024-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-14 16:00:00 9999999995-24-000473 333-276995 24641903 33 1840
2024-02-14 SC 13G/A kura13ga2024.htm 0000935836-24-000213 005-83933 24641008 34 47590
2024-02-14 CORRESP filename1.htm 0001193125-24-035631 7402
2024-02-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-000441 005-83933 24633196 34 277421
2024-02-13 SC 13G/A d10964193_13g-a.htm 0000919574-24-001075 005-83933 24630135 34 109449
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021309 005-83933 24628775 34 13125
2024-02-13 CORRESP filename1.htm 0001193125-24-033677 7684
2024-02-12 SC 13G/A e619259_sc13ga-kura.htm 0001193805-24-000194 005-83933 24621532 34 101062
2024-02-09 S-3 S-3 0001193125-24-030329 333-276995 24616231 33 307001
2024-02-05 D xslFormDX01/primary_doc.xml 06b 0001845459-24-000001 021-504346 24593592 33 15030
2024-01-31 4 4 0000950170-24-009496 8552
2024-01-31 4 4 0000950170-24-009495 4705
2024-01-31 4 4 0000950170-24-009494 4921
2024-01-31 4 4 0000950170-24-009493 8344
2024-01-30 144 xsl144X01/primary_doc.xml 0001973141-24-000055 001-37620 24578236 33 4457
2024-01-30 8-K 8-K 2.02,8.01,9.01 0001193125-24-018713 001-37620 24575797 34 12374437 1 1
2024-01-26 4 4 0000950170-24-008020 10389
2024-01-26 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-24-016715 001-37620 24567811 34 803185 1 1
2024-01-24 144 xsl144X01/primary_doc.xml 0001973141-24-000042 001-37620 24556535 33 4516
2024-01-24 SC 13G/A us50127t1097_012424.txt 0001086364-24-002271 005-83933 24555793 34 13710
2024-01-23 SC 13G/A Kura_Oncology_Inc.txt 0000093751-24-000076 005-83933 24550608 34 8543
2024-01-04 4 4 0000950170-24-001850 7862
2024-01-04 4 4 0000950170-24-001849 6926
2024-01-04 4 4 0000950170-24-001846 5309
2024-01-04 4 4 0000950170-24-001847 7082
2024-01-04 4 4 0000950170-24-001843 5304
2024-01-04 4 4 0000950170-24-001842 5313
2023-12-22 8-K 8-K 8.01,9.01 0001193125-23-301830 001-37620 231507397 34 345237 1 1
2023-12-11 4 FORM 4 SUBMISSION 0001209191-23-058040 7073
2023-11-02 S-3ASR S-3ASR 0001193125-23-269431 333-275279 231373101 33 1246717
2023-11-02 10-Q 10-Q 0000950170-23-058173 001-37620 231372199 34 7828856 1 1
2023-11-02 8-K 8-K 2.02,9.01 0000950170-23-058157 001-37620 231372101 34 359980 1 1
2023-09-21 SC 13G e618952_sc13g-kura.htm 0001193805-23-001309 005-83933 231269607 34 100275
2023-09-01 8-K 8-K 1.01 0001193125-23-227632 001-37620 231232509 34 144130 1 1
2023-08-16 4 FORM 4 SUBMISSION 0001209191-23-046002 5529
2023-08-16 3 FORM 3 SUBMISSION 0001209191-23-046001 6681
2023-08-09 10-Q 10-Q 0000950170-23-040556 001-37620 231155183 34 7686836 1 1
2023-08-03 8-K 8-K 2.02,9.01 0000950170-23-037994 001-37620 231140150 34 389335 1 1
2023-06-21 4 FORM 4 SUBMISSION 0001209191-23-038797 4963
2023-06-14 8-K 8-K 8.01,9.01 0001193125-23-166858 001-37620 231014163 34 658504 1 1
2023-06-14 424B5 424B5 0001193125-23-166854 333-251172 231014142 33 575638
2023-06-13 424B5 424B5 0001193125-23-166029 333-251172 231011318 33 556476
2023-06-12 8-K 8-K 8.01,9.01 0001193125-23-164835 001-37620 231007028 34 2999432 1 1
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033892 17273
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033888 5355
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033879 5343
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033871 5342
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033859 5392
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033850 5337
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033836 5358
2023-06-02 S-8 S-8 0000950170-23-026101 333-272389 23989467 33 260280
2023-06-02 8-K 8-K 5.02,5.07,9.01 0000950170-23-026086 001-37620 23989099 34 796410 1 1
2023-05-10 10-Q 10-Q 0000950170-23-020526 001-37620 23906564 34 6936013 1 1
2023-05-10 8-K 8-K 2.02,9.01 0000950170-23-020508 001-37620 23906352 34 344535 1 1
2023-05-04 DEFA14A DEFA14A 0000950170-23-017830 001-37620 23888581 34 56676
2023-04-20 ARS ARS 0000950170-23-013674 001-37620 23833145 34 5819449
2023-04-19 8-K 8-K 8.01,9.01 0001193125-23-105746 001-37620 23828532 34 161549 1 1
2023-04-06 DEFA14A DEFA14A 0000950170-23-012102 001-37620 23806932 34 1922713
2023-04-06 DEF 14A DEF 14A 0000950170-23-012096 001-37620 23806861 34 5017664 1 1
2023-03-10 8-K 8-K 7.01 0001193125-23-067513 001-37620 23723347 34 143912 1 1
2023-02-24 S-8 S-8 0000950170-23-004192 333-269974 23661360 33 265767
2023-02-23 10-K 10-K 0000950170-23-004107 001-37620 23659749 34 15197013 1 1
2023-02-23 8-K 8-K 2.02,9.01 0000950170-23-004098 001-37620 23659643 34 391268 1 1
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011289 7913
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011287 7181
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011285 5426
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011283 7206
2023-02-21 4 FORM 4 SUBMISSION 0001209191-23-011276 18003
2023-02-21 CT ORDER filename1.pdf 20230221,20230221 9999999997-23-000629 001-37620 23646036 34 130941
2023-02-14 SC 13G/A KURA ONCOLOGY, INC. 0000902664-23-001670 005-83933 23623463 34 59024
2023-02-14 SC 13G/A deeptrack-kura123122a1.htm 0001172661-23-000840 005-83933 23622987 34 102965
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000477 005-83933 23620675 34 276988
2023-02-13 SC 13G/A d9927321_13g-a.htm 0000919574-23-001040 005-83933 23616449 34 123756
2023-02-10 SC 13G/A kura13ga2022.htm 0000935836-23-000102 005-83933 23610291 34 47156
2023-02-10 SC 13G/A e618248_sc13ga-ko.htm 0001193805-23-000149 005-83933 23609060 34 99487
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-016317 005-83933 23603566 34 13015
2023-02-03 SC 13G/A Kura_Oncology_Inc.txt 0000093751-23-000145 005-83933 23584792 34 8488
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005753 4849
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005748 4862
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005746 7490
2023-01-31 4 FORM 4 SUBMISSION 0001209191-23-005744 7057
2023-01-31 SC 13G/A us50127t1097_013123.txt 0001306550-23-005107 005-83933 23571810 34 13450
2023-01-13 8-K 8-K 5.02 0001193125-23-008358 001-37620 23528889 34 144928 1 1
2023-01-09 8-K 8-K 2.02,8.01,9.01 0001193125-23-004159 001-37620 23516627 34 13953670 1 1
2022-12-12 8-K 8-K 8.01 0001193125-22-302283 001-37620 221456165 34 154117 1 1
2022-12-05 SC 13G THE SCHEDULE 13G 0000921895-22-003161 005-83933 221445586 34 285366
2022-11-18 4 FORM 4 SUBMISSION 0001209191-22-057874 5490
2022-11-03 8-K 8-K 8.01,9.01 0001193125-22-276906 001-37620 221358235 34 171093 1 1
2022-11-03 10-Q 10-Q 0000950170-22-021605 001-37620 221356497 34 7451383 1 1
2022-11-03 8-K 8-K 2.02,9.01 0000950170-22-021564 001-37620 221356287 34 413988 1 1
2022-11-03 8-K 8-K 1.01,2.03,3.02,7.01,9.01 0001193125-22-276373 001-37620 221356199 34 1093912 1 1
2022-11-03 424B5 424B5 0001193125-22-276361 333-251172 221356161 33 446914
2022-09-29 8-K 8-K 5.02 0001193125-22-254305 001-37620 221280550 34 152317 1 1
2022-08-03 10-Q 10-Q 0000950170-22-014251 001-37620 221132728 34 6888449 1 1
2022-08-03 8-K 8-K 2.02,9.01 0000950170-22-014242 001-37620 221132643 34 415771 1 1
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038944 8912
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038936 8919
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038931 8913
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038926 8925
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038922 8912
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038917 8967
2022-06-23 4 FORM 4 SUBMISSION 0001209191-22-038913 8911
2022-06-23 8-K 8-K 5.07 0000950170-22-012040 001-37620 221035935 34 229250 1 1
2022-05-04 10-Q 10-Q 0000950170-22-007404 001-37620 22891973 34 6288138 1 1
2022-05-04 8-K 8-K 2.02,9.01 0000950170-22-007388 001-37620 22891694 34 341364 1 1
2022-04-28 DEFA14A DEFA14A 0000950170-22-006540 001-37620 22866689 34 1915483
2022-04-28 DEF 14A DEF 14A 0000950170-22-006529 001-37620 22866502 34 2440636
2022-03-10 SC 13G/A filing.txt 0000315066-22-001482 005-83933 22727729 34 8057
2022-02-24 S-8 S-8 0001564590-22-006787 333-263000 22672887 33 214254
2022-02-24 8-K 8-K 1.01,1.02,9.01 0001193125-22-052342 001-37620 22672217 34 480023 1 1
2022-02-24 424B5 424B5 0001193125-22-052332 333-251172 22672140 33 504999
2022-02-24 10-K 10-K 0000950170-22-001967 001-37620 22671055 34 11966246 1 1
2022-02-24 8-K 8-K 2.02,9.01 0000950170-22-001964 001-37620 22670960 34 363084 1 1
2022-02-11 SC 13G/A d9166351_13g-a.htm 0000919574-22-000916 005-83933 22622251 34 127101
2022-02-11 SC 13G KURA_ONCOLOGY_INC.txt 0000093751-22-000296 005-83933 22619264 34 8529
2022-02-09 4 FORM 4 SUBMISSION 0001209191-22-008156 7912
2022-02-09 3 FORM 3 SUBMISSION 0001209191-22-008153 10539
2022-02-04 SC 13G deeptrack-kura012822.htm 0001172661-22-000237 005-83933 22590710 34 103008
2022-02-03 SC 13G/A us50127t1097_020222.txt 0000834237-22-005417 005-83933 22585655 34 13480
2022-02-01 8-K 8-K 5.02 0001193125-22-024600 001-37620 22579088 34 150705 1 1
2022-01-31 SC 13G kuraoncology13g.htm 0000935836-22-000043 005-83933 22574511 34 47160
2022-01-28 4 FORM 4 SUBMISSION 0001209191-22-005391 10768
2022-01-28 4 FORM 4 SUBMISSION 0001209191-22-005380 10959
2022-01-28 4 FORM 4 SUBMISSION 0001209191-22-005374 11005
2022-01-28 4 FORM 4 SUBMISSION 0001209191-22-005367 10805
2022-01-28 4 FORM 4 SUBMISSION 0001209191-22-005360 9057
2022-01-20 8-K 8-K 8.01 0001193125-22-013806 001-37620 22542552 34 143438 1 1
2022-01-10 SC 13G/A filing.txt 0000315066-22-000039 005-83933 22520721 34 8540
2021-12-09 SC 13G d9061703_13g.htm 0000919574-21-007370 005-83933 211482340 34 119906
2021-12-03 SC 13G e621131_sc13g-ko.htm 0001193805-21-001689 005-83933 211469746 34 99684
2021-11-24 8-K 8-K 8.01 0001193125-21-339334 001-37620 211441248 34 143731 1 1
2021-11-04 10-Q 10-Q 0001564590-21-054494 001-37620 211380211 34 6685523 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001564590-21-054488 001-37620 211380097 34 361890 1 1
2021-10-19 4 FORM 4 SUBMISSION 0001209191-21-060952 5458
2021-10-19 3 FORM 3 SUBMISSION 0001209191-21-060950 6649
2021-08-05 10-Q 10-Q 0001564590-21-041601 001-37620 211148440 34 12638637 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001564590-21-041588 001-37620 211148278 34 363024 1 1
2021-07-29 4 FORM 4 SUBMISSION 0001209191-21-048540 7655
2021-07-29 3 FORM 3 SUBMISSION 0001209191-21-048535 6613
2021-07-29 8-K 8-K 5.02,9.01 0001193125-21-228185 001-37620 211124849 34 173073 1 1
2021-06-25 8-K 8-K 5.07 0001564590-21-034591 001-37620 211047963 34 205225 1 1
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042792 5312
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042790 5311
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042788 5324
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042785 5308
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042782 5361
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042779 5306
2021-06-23 4 FORM 4 SUBMISSION 0001209191-21-042777 5348
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038237 5349
2021-06-04 3 FORM 3 SUBMISSION 0001209191-21-038227 6618
2021-06-04 DEFA14A DEFA14A 0001193125-21-182090 001-37620 21994873 34 24161
2021-06-04 8-K 8-K 5.02,9.01 0001193125-21-182056 001-37620 21994870 34 174240 1 1
2021-05-24 8-K 8-K 1.02 0001564590-21-029533 001-37620 21955498 34 165140 1 1
2021-05-17 8-K 8-K 1.01,2.03 0001564590-21-028255 001-37620 21928993 34 166570 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (316 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 91.88M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
dei EntityPublicFloat Entity Public Float USD 496.10M 2025-06-30 2025 FY 10-K 2026-03-05 0001193125-26-092567
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.61M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001193125-26-151335
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.29M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001193125-26-151335
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 6.49M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001193125-26-151335
ecd PeoTotalCompAmt PeoTotalCompAmt USD 4.74M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001193125-26-151335
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 83.72 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001193125-26-151335
ffd NetFeeAmt NetFeeAmt USD 0 2026-11-10 S-3ASR 2026-11-10 0001193125-26-455759
ffd TtlFeeAmt TtlFeeAmt USD 13,050 2026-11-10 S-3ASR 2026-11-10 0001193125-26-455759
ffd TtlOfferingAmt TtlOfferingAmt USD 150.00M 2026-11-10 S-3ASR 2026-11-10 0001193125-26-455759
ffd TtlOffsetAmt TtlOffsetAmt USD 13,050 2026-11-10 S-3ASR 2026-11-10 0001193125-26-455759
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-10 S-3ASR 2026-11-10 0001193125-26-455759
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 66.79M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263589
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 1.40M 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014251
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 8.13M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 1.06M 2015-09-30 2015 Q3 10-Q 2015-11-13 0001564590-15-010719
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 14.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 31,000 2020-03-31 2020 Q1 10-Q 2020-05-04 0001564590-20-020836
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 66.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 14.11M 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007404
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD -2.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 1.02M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 49,500 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.41B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8.17M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 294,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap AdvertisingExpense Advertising Expense USD 2.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 24.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 334,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 23.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap Assets Assets USD 566.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AssetsCurrent Assets, Current USD 534.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 0 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 21,000 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027950
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 10,000 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027950
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 67.77M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027950
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 8,100 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-050880
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 102.40M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026848
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 166.85M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026848
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 56.80M 2016-03-31 2016 Q1 10-Q 2016-05-11 0001564590-16-019115
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 332.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Amortized Cost USD 9.30M 2015-09-30 2015 Q3 10-Q 2015-11-13 0001564590-15-010719
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 434.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026848
us-gaap AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1 Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions security 22 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054494
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2.03M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263589
us-gaap Cash Cash USD 53.57M 2015-03-31 2015 Q1 10-Q 2015-05-13 0001564590-15-004193
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 57.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 105.96M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-01 0001564590-19-027967
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 57.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -91.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 4.00M 2016-09-30 2016 Q3 10-Q 2016-11-07 0001564590-16-027950
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 91.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 91.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CommonStockValue Common Stock, Value, Issued USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -215.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 63.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 380.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 2.04M 2014-12-31 2015 Q1 10-Q 2015-05-13 0001564590-15-004193
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 876,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CostsAndExpenses Costs and Expenses USD 288.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 7.25M 2020-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 10.00M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.06 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) pure 0.05 2022-11-02 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 300,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054494
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Security 36 2021-12-31 2021 FY 10-K 2022-02-24 0000950170-22-001967
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 328.00M 2022-06-30 2022 Q2 10-Q 2022-08-03 0000950170-22-014251
us-gaap DebtSecuritiesAvailableForSaleGainLoss Debt Securities, Available-for-sale, Gain (Loss) USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 411.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 60 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap DebtSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairment Debt Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 30.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.75M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 594,000 2019-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 367.64M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 7.94M 2020-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.34M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004107
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 111.46M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 10.49M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsOtherComprehensiveLoss Deferred Tax Assets, Other Comprehensive Loss USD 0 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 67.26M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 10.12M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 4.99M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 363.89M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 1.75M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap DeferredTaxLiabilitiesOtherComprehensiveIncome Deferred Tax Liabilities, Other Comprehensive Income USD 247,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap Depreciation Depreciation USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -268,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004291
us-gaap DerivativeLiabilities Derivative Liability USD 232,000 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 232,000 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 204,691 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 15,000 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap DueToOtherRelatedPartiesNoncurrent Due to Other Related Parties, Noncurrent USD 7,000 2014-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.49 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007404
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.272 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.023 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.031 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 18.41M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 18.00M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026848
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -212,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021094
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 80.84M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263589
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -278.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -211.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -30.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 2.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-28 0001144204-13-018035
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 75.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 9.52M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -58.47M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 116,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 6.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -309,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 264,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 8.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 3.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 14.81M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263589
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 923,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001564590-15-010719
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 5.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD 1,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-04 0001564590-20-020836
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 8,900 2007-11-16 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 5.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -30.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 196,000 2014-08-23 2014-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 24,002 2007-11-16 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 5.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 1,500 2007-11-16 2012-03-31 2012 Q1 10-Q 2012-05-15 0001144204-12-029113
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -226,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0000950170-22-021605
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 605,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -907,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001564590-15-004193
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -9.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 664,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001564590-15-004193
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 33.88M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-263589
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 414,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054494
us-gaap InterestAndOtherIncome Interest and Other Income USD 15.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap InterestExpense Interest Expense USD 804,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093997
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 46,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004291
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 627,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005293
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 998,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap InterestPayableCurrent Interest Payable, Current USD 24,002 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 1.09M 2020-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap InterestReceivable Interest Receivable USD 3.10M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap InventoryNet Inventory, Net USD 4.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 450,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011824
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 22.94M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 7.21M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 3.66M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 3.95M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 3.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.75M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 509,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6.95M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap Liabilities Liabilities USD 548.54M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 566.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LiabilitiesCurrent Liabilities, Current USD 148.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 6,000 2016-03-31 2016 Q1 10-Q 2016-05-11 0001564590-16-019115
us-gaap LineOfCreditFacilityCommitmentFeeAmount Line of Credit Facility, Commitment Fee Amount USD 300,000 2017-11-01 2017 FY 10-K 2018-03-12 0001564590-18-005293
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 20.00M 2017-05-31 2017 FY 10-K 2018-03-12 0001564590-18-005293
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 12.50M 2016-04-27 2017 Q3 10-Q 2017-11-07 0001564590-17-022269
us-gaap LongTermDebt Long-term Debt USD 9.70M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 8.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 2.33M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 3.32M 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004107
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 3.90M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021094
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 3.86M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 3.81M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 161,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001564590-17-022269
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -82,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006263
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 1 2015-03-06 2015 Q2 10-Q 2015-08-14 0001564590-15-007408
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 34.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 57.65M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011824
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 77.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -29.71M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011824
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -202.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -12.85M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011824
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -211.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 14.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 2.04M 2014-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 493,000 2014-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingExpenses Operating Expenses USD 371.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -226.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLeaseCost Operating Lease, Cost USD 503,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004107
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.88M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 14.12M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 741,000 2018-12-31 2018 FY 10-K 2019-03-05 0001564590-19-006263
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 500,000 2018-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 159,000 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 159,000 2016-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004291
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 159,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005293
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 300,000 2018-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.50M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054494
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.124 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 24,000 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 17.43M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -3.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -971,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 260,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 210,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-01 0000950170-25-061848
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 3.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 534,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001564590-15-007408
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 73,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-23 0000950170-23-004107
us-gaap PaymentsForDerivativeInstrumentInvestingActivities Payments for Derivative Instrument, Investing Activities USD 232,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 611,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021094
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 575,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 4.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 418.46M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123363
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 304.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2013-03-31 2013 Q1 10-Q 2013-05-15 0001144204-13-029422
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 23.13M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 707,000 2015-03-31 2015 Q1 10-Q 2015-05-13 0001564590-15-004193
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 4.29M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004291
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 31.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 5.00M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001564590-15-007408
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 10.00M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 303,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007404
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 172,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005293
us-gaap ProceedsFromLeasePayments Proceeds from Lease Payment, Operating Activity USD 900,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 387.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 710,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004291
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 411.93M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123363
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 6.00M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 829,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-024989
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 2.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ProfessionalFees Professional Fees USD 30,000 2015-03-05 2015-03-06 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 11.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 7.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 69,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 7.25M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021094
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 344,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-25 0001564590-20-006391
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 10,000 2007-11-16 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 194.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap RestrictedCash Restricted Cash USD 210,000 2023-06-30 2023 Q2 10-Q 2023-08-09 0000950170-23-040556
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 200,000 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093997
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.39B 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 61.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 93.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 24.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 15.19M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 9.81M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-029975
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 277,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 11.74 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.79 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 11.1 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 401,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 14.91 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.708 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001564590-15-010719
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.018 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001564590-15-010719
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 1.46M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 13.35M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2015-07-01 2015-09-30 2015 Q3 10-Q 2015-11-13 0001564590-15-010719
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.76 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005293
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 17.25 2024-01-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219481
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 17.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.5 2015-03-05 2015-03-06 2015 FY 10-K 2016-03-17 0001564590-16-014998
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.38M 2024-01-01 2024-01-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219481
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 7.62M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-14 0001564590-17-004291
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 303,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007404
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 31.54M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.01M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 2.26M 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054494
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 0 2020-12-31 2020 FY 10-K 2021-02-24 0001564590-21-007822
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 59,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346884
us-gaap TenantImprovements Tenant Improvements USD 1.00M 2020-03-31 2020 Q1 10-Q 2020-05-04 0001564590-20-020836
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 25.72M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 10.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 67,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-092567
us-gaap UnsecuredDebt Unsecured Debt USD 15,000 2014-12-31 2014 FY 10-K 2015-02-27 0001213900-15-001429
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 47.90M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021094
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 89.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 66.61M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-04 0000950170-22-007404
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 3.90M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001564590-15-007408
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 89.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455455

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →